Dew, is your disappointment limited to the amount to be received in 2008? I note the funding of clinical expenses vis. AD ind and bearing of all sales and marketing expense as well as the royalties that I assume are above and beyond the OA scope of this deal.
Market Data 
Markets 
AI
